Cargando…

Infliximab for medical induction of remission in Crohn's disease

BACKGROUND: Infliximab is a monoclonal antibody that binds and neutralises tumour necrosis factor‐alpha (TNF‐α), which is present in high levels in the blood serum, mucosa and stool of people with Crohn's disease. OBJECTIVES: To evaluate the benefits and harms of infliximab alone or in combinat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gordon, Morris, Sinopoulou, Vassiliki, Akobeng, Anthony K, Radford, Shellie J, Eldragini, Mohsen, Darie, Ana-Maria, Moran, Gordon William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658649/ https://www.ncbi.nlm.nih.gov/pubmed/37982428 http://dx.doi.org/10.1002/14651858.CD012623.pub2

Ejemplares similares

Vedolizumab for induction and maintenance of remission in Crohn's disease
por: Hui, Samuel, et al.
Publicado: (2023)

Patient education interventions for the management of inflammatory bowel disease
por: Gordon, Morris, et al.
Publicado: (2023)

Minimum sample size estimates for trials in inflammatory bowel disease: A systematic review of a support resource
por: Gordon, Morris, et al.
Publicado: (2021)

Remote care through telehealth for people with inflammatory bowel disease
por: Gordon, Morris, et al.
Publicado: (2023)

Sample‐size estimation is not reported in 24% of randomised controlled trials of inflammatory bowel disease: A systematic review
por: Iheozor‐Ejiofor, Zipporah, et al.
Publicado: (2021)

Outcomes of Pediatric Patients with Crohn's Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission
por: Lv, Yao, et al.
Publicado: (2022)

The relationship between Central Nervous System morphometry changes and key symptoms in Crohn’s disease
por: Thapaliya, Gita, et al.
Publicado: (2022)

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
por: Vande Casteele, Niels, et al.
Publicado: (2015)

5-Aminosalicylates to maintain remission in Crohn’s disease: Interpreting conflicting systematic review evidence
por: Gordon, Morris
Publicado: (2017)

Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn’s disease: a systematic review
por: Gordon, Morris, et al.
Publicado: (2020)

Racecadotril for acute diarrhoea in children: systematic review and meta-analyses
por: Gordon, Morris, et al.
Publicado: (2016)

Discontinuation of Scheduled Infliximab in Crohn’s Patients With Clinical Remission: A Retrospective Single-Center Study
por: Hu, Huiqin, et al.
Publicado: (2017)

Delphi consensus survey: the opinions of patients living with refractory ulcerative proctitis and the health care professionals who care for them
por: Kyriacou, Maro, et al.
Publicado: (2023)

Stakeholder-identified barriers and enablers to ultrasound implementation in inflammatory bowel disease services in the UK: a qualitative interview study
por: Radford, Shellie, et al.
Publicado: (2023)

Infliximab in the treatment of Crohn’s disease
por: Poggioli, Gilberto, et al.
Publicado: (2007)

Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients
por: Szczubełek, Martyna, et al.
Publicado: (2021)

The impact of medication belief on adherence to infliximab in patients with Crohn’s disease
por: Li, Shuyan, et al.
Publicado: (2023)

Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial
por: Stamm, Tanja Alexandra, et al.
Publicado: (2018)

Infliximab to treat Crohn’s disease: an update
por: Cottone, M, et al.
Publicado: (2011)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

Induction of remission in diabetes by lowering blood glucose
por: Weir, Gordon C., et al.
Publicado: (2023)

Remission of Refractory Celiac Disease With Infliximab in a Pediatric Patient
por: Rawal, Nidhi, et al.
Publicado: (2015)

Profile of infliximab in the treatment of pediatric Crohn’s disease
por: Kierkus, Jaroslaw, et al.
Publicado: (2015)

Metastatic Crohn’s disease despite infliximab therapy
por: Campos, Sara, et al.
Publicado: (2017)

Myelolipoma After Infliximab Treatment for Crohn's Disease
por: Cesa, Kevin, et al.
Publicado: (2022)

Budesonide for the Induction and Maintenance of Remission in Crohn’s Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration
por: Kuenzig, M Ellen, et al.
Publicado: (2018)

The Role of Partial Enteral Nutrition for Induction of Remission in Crohn’s Disease: A Systematic Review of Controlled Trials
por: González-Torres, Lucía, et al.
Publicado: (2022)

Proactive measurement of infliximab drug levels in children with Crohn’s disease
por: Holland, Kathleen, et al.
Publicado: (2022)

Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis
por: Hassan, Elham A., et al.
Publicado: (2017)

Long-Term Clinical Remission in Biologically Naïve Crohn's Disease Patients with Adalimumab Therapy, Including Analyses of Switch from Adalimumab to Infliximab
por: Mizoshita, Tsutomu, et al.
Publicado: (2016)

Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study
por: Miheller, Pál, et al.
Publicado: (2009)

Loss of Response to Long-Term Infliximab Therapy in Children with Crohn’s Disease
por: Gouldthorpe, Oliver, et al.
Publicado: (2013)

Induction of Remission in Pediatric Crohn’s Disease Patients Assessed by the Mucosal Inflammation Noninvasive Index
por: Herman, Roma, et al.
Publicado: (2021)

Adalimumab for induction of remission in patients with Crohn's disease: a systematic review and meta-analysis
por: Yin, Juntao, et al.
Publicado: (2022)

Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017)

Infliximab therapy in pediatric Crohn’s disease: a review
por: Parashette, Kalyan Ray, et al.
Publicado: (2010)

Maintenance treatment with infliximab for the management of Crohn’s disease in adults
por: Caviglia, Renato, et al.
Publicado: (2009)

Infliximab-induced intertriginous psoriasis in patient with Crohn's disease
por: Mola, Federica, et al.
Publicado: (2011)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
por: Kim, You Lim, et al.
Publicado: (2014)

Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
por: Timper, Katharina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3ci1dmgpvn395r0nsl74oigreh